Why the study?
Does vitronectin blockade prevent neointima formation and smooth muscle cell migration after vascular injury?
Does vitronectin blockade prevent neointima formation and smooth muscle cell migration after vascular injury?
Vitronectin blockade reduces neointima formation and smooth muscle cell migration following vascular injury, highlighting a potential therapeutic target for preventing restenosis.
No takes yet. Share an insight, caveat, or question.
May support vitronectin blockade to limit neointimal hyperplasia; leaves open translation to human restenosis prevention.
Pascale Dufourcq (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: